Drug development companies are working to increase the chances of clinical success by improving biomarker identification, validation, and analysis.

Market leader in digital transformation and staffing services for science-based businesses becomes a Sapio Services Partner .

Ultrasound technology could be key to enabling the biological breakdown of so-called 'forever chemicals', say researchers ...

Usmarapride is under clinical development by Suven Life Sciences and currently in Phase I for Cognitive Disorders.

HEALWELL’s subsidiary, BioPharma Services, is expanding into late-stage patient trials through the integration of Canadian ...

Usmarapride is under clinical development by Suven Life Sciences and currently in Phase I for Alzheimer's Disease.

Sapio Sciences, the science-aware™ lab informatics platform, today announced significant enhancements to Sapio ELaiN, the ...

In a recent article, researchers introduced a multifunctional sPEEK implant enhanced with BP/PDA and E7, offering superior ...

The growth of the global Preclinical CRO market is driven by several key factors. Increasing complexity and costs associated ...

Tonnes of dead fish, mussels and snails were seen floating on the River Oder (Germany) in early August 2022. It soon became ...

Ultrasound technology could be key to enabling the biological breakdown of so-called ‘forever chemicals’, say researchers at ...